脾边缘区淋巴瘤肿瘤微环境中免疫耗竭与免疫抑制的特征分析
本研究对36例脾边缘区淋巴瘤(sMZL)脾脏标本进行单细胞分析,发现sMZL肿瘤微环境不同于对照非恶性反应性脾脏,表现为ICOS+ TFH细胞增多、TIGIT+ Treg细胞富集并抑制TH17和TH22细胞,以及CD8+ T细胞存在短寿命、耗竭和晚期分化亚群,PD-1低表达细胞上TIM-3表达可识别严重免疫功能障碍的细胞。
要点
- sMZL脾脏TME中ICOS+ TFH细胞较反应性脾脏增多,且与记忆B细胞数量正相关。
- sMZL中TIGIT+ Treg细胞富集,与TH17和TH22细胞抑制相关。
- PD-1低表达细胞上TIM-3表达可识别严重免疫功能障碍的细胞。
核心结论
- sMZL的肿瘤微环境整体及T细胞群体具有异质性,免疫耗竭是损害T细胞功能的主要因素之一。
研究设计与样本
- 研究采用单细胞分析技术,对36例sMZL脾脏标本进行评估,并与对照非恶性反应性脾脏进行比较。
主要发现
- sMZL中TFH细胞数量变化很大,ICOS+ TFH细胞在sMZL中较反应性脾脏更丰富,且TFH细胞与记忆B细胞数量增加正相关。
- sMZL中TIGIT+ Treg细胞富集,并与TH17和TH22细胞抑制相关。
- 肿瘤内CD8+ T细胞由短寿命、耗竭和晚期分化亚群组成,功能受损。
- sMZL中存在T细胞耗竭,PD-1低表达细胞上TIM-3表达可识别严重免疫功能障碍的细胞,CITE-seq分析验证了该发现。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of the tumor microenvironment (TME) and intratumoral T cells in splenic marginal zone lymphoma (sMZL) is largely unknown. In the present study, we evaluated 36 sMZL spleen specimens by single cell analysis to gain a better understanding of the TME in sMZL. Using mass cytometry (CyTOF), we observed that the TME in sMZL is distinct from that of control non-malignant reactive spleen (rSP). We found that the number of TFH cells varied greatly in sMZL, ICOS+ TFH cells were more abundant in sMZL than rSP, and TFH cells positively correlated with increased numbers of memory B cells. Treg cell analysis revealed that TIGIT+ Treg cells are enriched in sMZL and correlate with suppression of TH17 and TH22 cells. Intratumoral CD8+ T cells were comprised of subsets of short-lived, exhausted and late-stage differentiated cells, thereby functionally impaired. We observed that T-cell exhaustion was present in sMZL and TIM-3 expression on PD-1low cells identified cells with severe immune dysfunction. Gene expression profiling by CITE-seq analysis validated this finding. Taken together, our data suggest that the TME as a whole, and T-cell population specifically, are heterogenous in sMZL and immune exhaustion is one of the major factors impairing T-cell function.
引用
- Anagnostou T, Yang ZZ, Jalali S, et al. Characterization of immune exhaustion and suppression in the tumor microenvironment of splenic marginal zone lymphoma. Leukemia. 2023. PMID: 37117318. doi:10.1038/s41375-023-01911-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。